Company information:
Azenco4 Limited (No: 09965954)
Address: 1 FRANCIS CRICK AVENUE, CAMBRIDGE BIOMEDICAL CAMPUS, CAMBRIDGE, CB2 0AA, UNITED KINGDOM
Status: Active
Incorporated: 22-Jan-2016
Accounts Next Due: 30-Sep-2024
Next Confirmation Statement Due: 02-Apr-2025
Industry Class: 82990 - Other business support service activities n.e.c.
Current Director: MATTHEW SHAUN BOWDEN ( DOB: Dec-1977 From: Feb-2019 )
Current Director: MATTHEW SHAUN BOWDEN ( DOB: Dec-1977 From: Feb-2019 )
Current Director: IAIN ALISTAIR COLLINS ( DOB: Dec-1970 From: May-2017 )
Current Director: ADRIAN CHARLES NOEL KEMP ( DOB: Nov-1966 From: Jan-2016 )
Current Secretary: CAMILLA JANE JOHNSTONE ( From: Sep-2019 )
Resigned Director: IAN MARTIN DAVID BRIMICOMBE ( DOB: Oct-1963 From: Jan-2016 To: May-2017 )
Resigned Director: KATIE LOUISE JACKSON-TURNER ( DOB: Oct-1966 From: Mar-2017 To: Feb-2019 )
Resigned Secretary: MATTHEW IAN CONACHER ( From: Mar-2017 To: Sep-2019 )
Persons of Significant Control:
Astrazeneca Treasury Limited, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, England: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2016-04-06)